UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Surgery With or Without Preoperative Paclitaxel and Carboplatin in Early-Stage Non–Small-Cell Lung Cancer: Southwest Oncology Group Trial S9900, an Intergroup, Randomized, Phase III Trial

Journal of clinical oncology, 2010-04, Vol.28 (11), p.1843-1849

2010

Volltextzugriff (PDF)

Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non–Small-Cell Lung Cancer Guideline

Journal of clinical oncology, 2007-12, Vol.25 (34), p.5506-5518

2007

Volltextzugriff (PDF)

Adjuvant Chemotherapy in Completely Resected Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2005-05, Vol.23 (14), p.3270-3278

2005

Volltextzugriff (PDF)

Trimodality Therapy for Superior Sulcus Non-Small Cell Lung Cancer: Southwest Oncology Group-Intergroup Trial S0220

The Annals of thoracic surgery, 2014-08, Vol.98 (2), p.402-410

2014

Volltextzugriff (PDF)

Adjuvant Chemotherapy for Non–Small-Cell Lung Cancer — The Smoke Clears

The New England journal of medicine, 2005-06, Vol.352 (25), p.2640-2642

Pisters, Katherine M.W

2005

Volltextzugriff (PDF)

Phase I Trial of Oral Green Tea Extract in Adult Patients With Solid Tumors

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1830-1838

2001

Volltextzugriff (PDF)

Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpressing disease

Lung cancer (Amsterdam, Netherlands), 2004-04, Vol.44 (1), p.99-110

2004

Volltextzugriff (PDF)

Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint

The lancet oncology, 2014, Vol.15 (1), p.e42-e50

2014

Volltextzugriff (PDF)

Dose Escalation of Gemcitabine Is Possible With Concurrent Chest Three-Dimensional Rather Than Two-Dimensional Radiotherapy: A Phase I Trial in Patients With Stage III Non–Small-Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2009, Vol.73 (1), p.119-127

2009

Volltextzugriff (PDF)

Comparative effectiveness of stereotactic radiosurgery versus whole‐brain radiation therapy for patients with brain metastases from breast or non–small cell lung cancer

Cancer, 2016-07, Vol.122 (13), p.2091-100

2016

Volltextzugriff (PDF)

Cisplatin, Etoposide, and Paclitaxel in the Treatment of Patients With Extensive Small-Cell Lung Carcinoma

Journal of clinical oncology, 1999-08, Vol.17 (8), p.2309-2315

1999

Volltextzugriff (PDF)

Association of Medicaid Insurance With Survival Among Patients With Small Cell Lung Cancer

JAMA network open, 2020-04, Vol.3 (4), p.e203277-e203277

2020

Volltextzugriff (PDF)

Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane‐refractory/resistant nonsmall cell lung carcinoma

Cancer, 2005-08, Vol.104 (3), p.561-569

2005

Volltextzugriff (PDF)

Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 1999-05, Vol.91 (9), p.763-771

1999

Volltextzugriff (PDF)

Phase II study of pemetrexed in combination with carboplatin in the first‐line treatment of advanced nonsmall cell lung cancer

Cancer, 2005-12, Vol.104 (11), p.2449-2456

2005

Volltextzugriff (PDF)

Pathologic response after neoadjuvant chemotherapy in resectable non-small cell lung cancers: proposal for the use of “major pathologic response” as a surrogate endpoint

The lancet oncology, 2014-01, Vol.15 (1), p.e42-e50

2014

Volltextzugriff (PDF)

Induction of p53-regulated Genes and Tumor Regression in Lung Cancer Patients after Intratumoral Delivery of Adenoviral p53 (INGN 201) and Radiation Therapy

Clinical cancer research, 2003-01, Vol.9 (1), p.93-101

2003

Volltextzugriff (PDF)

The IASLC Lung Cancer Staging Project: “The Nodal Zone

Journal of thoracic oncology, 2007-07, Vol.2 (7), p.583-584

2007

Volltextzugriff (PDF)

New Chemotherapeutic Agents for Non-small Cell Lung Cancer

Chest, 1995-06, Vol.107 (6), p.306S-311S

1995

Volltextzugriff (PDF)

Adjuvant and neoadjuvant therapy for early stage non[ndash ]small cell lung cancer

Seminars in oncology, 2001-08, Vol.28 (4L), p.23-28, Article asonc02804l0023

Pisters, Katherine M.W.

2001

Volltextzugriff (PDF)

Neoadjuvant Chemotherapy for Resectable Non-Small Cell Lung Cancer

Lung Cancer, 2014, p.290-308

2014

Volltextzugriff (PDF)

Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients

The Annals of thoracic surgery, 1993-06, Vol.55 (6), p.1365-1374

1993

Volltextzugriff (PDF)

Induction Chemotherapy for Resectable Lung Cancer

Lung Cancer, 2008, p.233-246

2008

Volltextzugriff (PDF)

Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer

Journal of clinical oncology, 1994-06, Vol.12 (6), p.1232-1237

1994

Volltextzugriff (PDF)

A multidisciplinary approach to therapy for unresectable malignant thymoma

Annals of internal medicine, 1998-07, Vol.129 (2), p.100

1998

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(51)
Buchkapitel
(3)

Sprache

Englisch
(54)

Erscheinungsjahr

n.n

Thema

Humans
(43)
Life Sciences & Biomedicine
(38)
Science & Technology
(38)
Female
(33)
Male
(33)
Oncology
(33)
Biological And Medical Sciences
(31)
Medical Sciences
(31)
Middle Aged
(30)
Aged
(27)
Adult
(23)
Pharmacology. Drug Treatments
(22)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(21)
Lung Neoplasms - Drug Therapy
(21)
Chemotherapy
(18)
Lung Neoplasms - Pathology
(16)
Antineoplastic Agents
(13)
Carcinoma, Non-Small-Cell Lung - Pathology
(13)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(12)
Cisplatin - Administration & Dosage
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Surgery With or Without Preoperative Paclitaxel and Carboplatin in Early-Stage Non–Small-Cell Lung Cancer: Southwest Oncology Group Trial S9900, an Intergroup, Randomized, Phase III Trial

Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non–Small-Cell Lung Cancer Guideline

Adjuvant Chemotherapy in Completely Resected Non–Small-Cell Lung Cancer

Trimodality Therapy for Superior Sulcus Non-Small Cell Lung Cancer: Southwest Oncology Group-Intergroup Trial S0220

Adjuvant Chemotherapy for Non–Small-Cell Lung Cancer — The Smoke Clears

Phase I Trial of Oral Green Tea Extract in Adult Patients With Solid Tumors

Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpressing disease

Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint

Dose Escalation of Gemcitabine Is Possible With Concurrent Chest Three-Dimensional Rather Than Two-Dimensional Radiotherapy: A Phase I Trial in Patients With Stage III Non–Small-Cell Lung Cancer

Comparative effectiveness of stereotactic radiosurgery versus whole‐brain radiation therapy for patients with brain metastases from breast or non–small cell lung cancer

Cisplatin, Etoposide, and Paclitaxel in the Treatment of Patients With Extensive Small-Cell Lung Carcinoma

Association of Medicaid Insurance With Survival Among Patients With Small Cell Lung Cancer

Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane‐refractory/resistant nonsmall cell lung carcinoma

Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer

Phase II study of pemetrexed in combination with carboplatin in the first‐line treatment of advanced nonsmall cell lung cancer

Pathologic response after neoadjuvant chemotherapy in resectable non-small cell lung cancers: proposal for the use of “major pathologic response” as a surrogate endpoint

Induction of p53-regulated Genes and Tumor Regression in Lung Cancer Patients after Intratumoral Delivery of Adenoviral p53 (INGN 201) and Radiation Therapy

The IASLC Lung Cancer Staging Project: “The Nodal Zone

New Chemotherapeutic Agents for Non-small Cell Lung Cancer

Adjuvant and neoadjuvant therapy for early stage non[ndash ]small cell lung cancer

Neoadjuvant Chemotherapy for Resectable Non-Small Cell Lung Cancer

Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients

Induction Chemotherapy for Resectable Lung Cancer

Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer

A multidisciplinary approach to therapy for unresectable malignant thymoma

Suchergebnisse filtern